Literature DB >> 31928293

Prevalence and Factors Associated With Intimate Partner Violence Among Women in Haiti: Understanding Household, Individual, Partner, and Relationship Characteristics.

James R Occean1, Nicholas Thomas1, Andrew C Lim1, Sharonda M Lovett1, Abimbola Michael-Asalu1, Abraham A Salinas-Miranda1,2.   

Abstract

Intimate partner violence (IPV) is a significant public health issue with detrimental consequences for women's reproductive, mental, and physical health. In Haiti, IPV is a major obstacle to women's development. Yet, the determinants of IPV victimization are still not well understood. In this study, we utilized the 2016-2017 Haiti Demographic and Health Survey to determine the prevalence of IPV victimization and its subtypes (emotional, physical, and sexual abuse) among married or cohabiting women (N = 3,805) of reproductive age (15-49) by their current husband/partner. Logistic regression was conducted to explore the association between IPV and household, individual, husband/partner, and relationship characteristics. The prevalence of IPV victimization was 32.5% with the majority reporting emotional (24.7%) followed by physical (16.8%) and sexual (10.5%) violence. Increased odds of IPV victimization were found among women with children in the household (adjusted odds ratio [AOR] = 1.45, 95% confidence interval [CI] = [1.03, 2.02]), with attitudinal acceptance of wife-beating (AOR = 1.45, 95% CI = [1.05, 2.02]), and those who witnessed their father beating their mother (AOR = 1.49, 95% CI = [1.18, 2.67]). Higher odds of reporting IPV victimization were also found among women whose partner drank alcohol (AOR = 2.89, 95% CI = [2.29, 3.65]), who were in a polygynous relationship (AOR = 1.76, 95% CI = [1.23, 2.40]), and displayed one or more controlling behaviors (AOR = 1.92, 95% CI = [1.42, 2.59]). Women who reported being afraid of their partner had greater odds of IPV victimization (AOR = 16.22, 95% CI = [8.38, 31.39]). Decreased odds of reporting IPV were associated with women living in rural areas (AOR = 0.73, 95% CI = [0.53, 1.00]) and those unmarried, but living with their partner (AOR = 0.62, 95% CI = [0.43, 0.90]). Our findings identify subgroups of women in Haiti that may be vulnerable to IPV victimization. Thus, we recommend a differentiated approach to IPV prevention strategies and interventions that consider women's family structure in the household as well as individual, partner, and relationship characteristics.

Entities:  

Keywords:  Haiti; adult victims; alcohol and drugs; anything related to domestic violence; domestic violence; domestic violence and cultural contexts; intimate partner violence; predicting domestic violence; sexual assault

Year:  2020        PMID: 31928293     DOI: 10.1177/0886260519898443

Source DB:  PubMed          Journal:  J Interpers Violence        ISSN: 0886-2605


  4 in total

1.  Prevalence and associated factors of intimate partner violence (IPV) against women in Bangladesh amid COVID-19 pandemic.

Authors:  Istihak Rayhan; Khaleda Akter
Journal:  Heliyon       Date:  2021-03-30

2.  Trends and correlates of intimate partner violence (IPV) victimization in Rwanda: results from the 2015 and 2020 Rwanda Demographic Health Survey (RDHS 2015 and 2020).

Authors:  Claire Bahati; Josias Izabayo; Pascaline Munezero; Japhet Niyonsenga; Léon Mutesa
Journal:  BMC Womens Health       Date:  2022-09-06       Impact factor: 2.742

3.  Typologies of Intimate Partner Violence Against Women in Five Latin-American Countries: A Latent Class Analysis.

Authors:  Alexandra Restrepo; Nilton Montoya; Laura Zuluaga
Journal:  Int J Public Health       Date:  2022-08-19       Impact factor: 5.100

Review 4.  Identifying the Impact of Intimate Partner Violence in Humanitarian Settings: Using an Ecological Framework to Review 15 Years of Evidence.

Authors:  Melissa Meinhart; Ilana Seff; Katrina Troy; Samantha McNelly; Luissa Vahedi; Catherine Poulton; Lindsay Stark
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.